The U.S. Food and Drug Administration (FDA) has issued an early alert regarding a sterility defect affecting Cardinal Health Webcol Large Alcohol Prep Pads distributed within custom convenience kits manufactured by Aligned Medical Solutions. The non-sterile pads pose a risk of infection if used in clinical or procedural settings where sterile conditions are required.
Key takeaways
- Cardinal Health Webcol Large Alcohol Prep Pads in custom convenience kits manufactured by Aligned Medical Solutions fail sterility requirements
- The FDA issued an early alert (not a full recall) to allow healthcare facilities and providers to take immediate precautionary action
- Non-sterile prep pads carry infection risk and should not be used for procedures requiring aseptic technique
- Healthcare facilities should verify product origins and confirm sterility status before clinical use
Product Safety Classification Timeline
FDA alert progression for medical device safety concerns
Source: FDA Medical Device Recall Categories | Georgian Medical Journal News
What is an FDA Early Alert?
An early alert differs from a formal recall in that it communicates a potential safety concern before the FDA has completed its investigation or classification of the hazard. Healthcare providers and facilities receive notice to take precautions while the agency gathers information on the scope and severity of the defect.
Early alerts are issued when there is reasonable evidence of a product defect but the full extent of affected units or patient impact remains under evaluation. This approach allows the healthcare system to implement interim safeguards without waiting for the lengthy formal recall process. Facilities are advised to quarantine affected products and verify the sterility status of any Cardinal Health Webcol pads obtained through custom convenience kits.
Infection Risk and Clinical Practice Implications
Non-sterile alcohol prep pads used before injections, venipuncture, or skin procedures substantially increase the risk of skin and soft-tissue infections, including bacterial and fungal colonization. The risk is heightened in immunocompromised patients, those with indwelling catheters, or those undergoing repeated procedures in healthcare settings.
Alcohol prep pads failing sterility testing carry unacceptable infection risk and should be immediately removed from clinical use and replaced with verified sterile alternatives.
— U.S. Food and Drug Administration, Medical Device Early Alert (2025)
Healthcare facilities using custom convenience kits containing Cardinal Health Webcol Large Alcohol Prep Pads should immediately verify lot numbers and manufacturing dates against FDA guidance. Any affected pads must be quarantined and segregated from patient care supplies. Clinicians should ensure that replacement sterile prep pads from verified suppliers are available before potential shortages occur due to heightened scrutiny. For more information on quality assurance in clinical settings, see GMJ’s Quality & Safety coverage.
Manufacturer and Distributor Responsibilities
Aligned Medical Solutions, the manufacturer of the custom convenience kits, bears responsibility for ensuring all components—including sourced products like Cardinal Health Webcol pads—meet published sterility and safety standards before distribution. Cardinal Health, as the original product manufacturer, is also engaged in the FDA’s ongoing assessment.
Healthcare facilities should contact their suppliers immediately to identify which convenience kits contain affected pads and request documentation of sterility testing or product replacement. The FDA’s early alert page will be updated as new information becomes available. Providers are encouraged to report any adverse events (infections potentially linked to these pads) directly to the FDA MedWatch program or through their institution’s quality and safety office.
What this means
Frequently asked questions
What should I do if my healthcare facility uses these convenience kits?
Contact your supplier immediately to identify affected lot numbers. Quarantine any pads matching the FDA alert criteria and replace them with sterile alternatives from verified sources. Document the action taken and report any potential infections to your quality and safety officer.
How do I know if an alcohol prep pad is sterile?
Sterile medical devices must bear clear labeling indicating sterility assurance level (SAL) and manufacturing/expiration dates. The packaging should be intact and unopened. If pads are sourced through custom convenience kits, verify the kit manufacturer’s documentation confirming sterility testing and certification.
What is the difference between an early alert and a recall?
An early alert signals a potential safety concern while investigation is ongoing; a recall is a formal action requiring the removal or correction of a product. Early alerts allow healthcare facilities to take precautions immediately rather than wait for full recall procedures.
The FDA continues to investigate the scope of the sterility defect affecting Cardinal Health Webcol pads in Windstone Medical Packaging’s convenience kits. Healthcare facilities should monitor the FDA’s website for updates and remain vigilant for any signs of infection in patients who may have been exposed to affected pads. Transparency from manufacturers and rapid communication from regulators remain essential to maintaining trust in the safety of medical device supply chains. For updates on medical device safety and quality assurance, visit GMJ News.
Source: FDA Early Alert: Convenience Kit Issue from Windstone Medical Packaging, Inc.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
